+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Direct Fed Microbial Market by Product Type and Livestock: Global Opportunity Analysis and Industry Forecast, 2019-2026

  • ID: 5118780
  • Report
  • April 2020
  • Region: Global
  • 205 Pages
  • Allied Analytics LLP

FEATURED COMPANIES

  • Adisseo
  • Bio-Vet
  • CHR. Hansen A/S
  • Evonik Industries Ag
  • Kemin Industries Inc.
  • Koninklijke DSM N. V
The global direct fed microbial market was valued at $980 million in 2018 and is expected to reach $1,772 million by 2026, registering a CAGR of 7.5% from 2019 to 2026.



Direct-fed microbial or probiotics are live microorganisms that are beneficial to the gut health. These probiotics are included in the diet of animals to promote their growth and development. In addition, they help to boost the immune system of animals, and thus prevent the growth of pathogenic organisms in the gut. The use of probiotic organisms is replacing antibiotic usage to enhance the health and performance of livestock animals. The administration of these products plays an important role to enhance cost reduction, feed digestibility, and nutrient absorption, which, in turn, promotes the growth of animals. In addition, various kinds of bacteria such as Lactobacillus and Bifidobacterium are being used in many animal producers.

Major factor that drives the growth of the global direct-fed microbial market include increase in demand for meat & milk consumption. Surge in human population and increase in demand for proteinous diet further boost market growth. In addition, probiotics aids nutrient absorption by breaking down the complex compounds, which, in turn, helps to reduce the cost of animal production and increases the profitability of the animal producers. However, implementation of stringent regulations regarding the vigorous usage of these microorganisms in animal diet and increase in cost of production are the major factors hampering the market growth. On the contrary, ban on the usage of antibiotics in animal diet in the developed nations such the U.S., Germany, and the UK and rise in animal health concerns are some of the major factors expected to create lucrative opportunities in the near future.

The global direct-fed microbial market is segmented into product type, livestock, and region. By product type, the market is categorized into lactic acid bacteria, Bacillus, and other organisms. Depending on livestock, the market is classified into swine, poultry, ruminants, aquatic animals, and other livestock animals. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Comprehensive competitive analysis and profiles of major market players such as Koninklijke DSM N.V BIO-VET, Archer-Daniels-Midland Company., Chr. Hansen A/S., Biomin Holding GmbH., E. I. DU Pont De Nemours And Company., Novozymes, Kemin Industries, Inc., and Novus International, Inc. are provided in this report.

KEY BENEFITS FOR STAKEHOLDERS
  • This report entails a detailed quantitative analysis along with the current global direct fed microbial market trends from 2019 to 2026 to identify the prevailing opportunities along with the strategic assessments.
  • The market size and estimations are based on a comprehensive analysis of key developments in the industry.
  • A qualitative analysis based on innovative products facilitates strategic business planning.
  • The development strategies adopted by the key market players are enlisted to understand the competitive scenario of the market

Key Market Segments

By Product Type
  • Lactic Acid Bacteria
  • Bacillus
  • Others

By Livestock
  • Swine
  • Poultry
  • Ruminants
  • Aquatic Animals
  • Others

By Region
  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Rest of Europe
  • Asia-Pacific
  • Japan
  • China
  • India
  • Rest of Asia-Pacific
  • LAMEA
  • Brazil
  • Saudi Arabia
  • South Africa
  • Rest of LAMEA

List of key players profiled in the report:
  • Koninklijke DSM N. V
  • BIO-VET
  • Archer-Daniels-Midland Company
  • CHR. Hansen A/S
  • E. I. Du Pont De Nemours And Company
  • Novozymes A/S
  • Kemin Industries, Inc.
  • BASF SE (BASF Corporation)
  • Evonik Industries Ag
  • Adisseo

LIST OF OTHER PLAYERS IN THE VALUE CHAIN (These players are not profiled in the report. The same will be included on request)
  • GlaxoSmithKline plc
  • Novo Nordisk A/S
Frequently Asked Questions about the Global Direct Fed Microbial Market

What is the estimated value of the Global Direct Fed Microbial Market?

The Global Direct Fed Microbial Market was estimated to be valued at $980.0 million in 2018.

What is the growth rate of the Global Direct Fed Microbial Market?

The growth rate of the Global Direct Fed Microbial Market is 7.7%, with an estimated value of $1772.0 million by 2026.

What is the forecasted size of the Global Direct Fed Microbial Market?

The Global Direct Fed Microbial Market is estimated to be worth $1772.0 million by 2026.

Who are the key companies in the Global Direct Fed Microbial Market?

Key companies in the Global Direct Fed Microbial Market include Koninklijke DSM N. V, Bio, Vet, Archer, Daniels, Midland Company, CHR. Hansen A/S, E. I. Du Pont De Nemours And Company and Kemin Industries Inc..
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Adisseo
  • Bio-Vet
  • CHR. Hansen A/S
  • Evonik Industries Ag
  • Kemin Industries Inc.
  • Koninklijke DSM N. V

Chapter 1: Introduction
1.1. Report Description
1.2. Key Benefits for Stakeholders
1.3. Research Methodology
1.3.1. Secondary Research
1.3.2. Primary Research
1.3.3. Analyst Tools & Models
Chapter 2: Executive Summary
2.1. Cxo Perspective
Chapter 3: Market Overview
3.1. Market Definition and Scope
3.2. Porter's Five Forces Analysis
3.3. Top Player Positioning
3.4. Market Dynamics
3.4.1. Drivers
3.4.1.1. Surge in Demand for Meat and Milk
3.4.1.2. High Need for Probiotics to Save Cost
3.4.2. Restraints
3.4.2.1. Increase in Cost of Production
3.4.3. Opportunity
3.4.3.1. Rise in Concerns Regarding the Use of Antibiotics in Animals
Chapter 4: Direct Fed Microbial Market, by Product Type
4.1. Overview
4.1.1. Market Size and Forecast, by Type
4.2. Lactic Acid Bacteria
4.2.1. Key Market Trends and Opportunities
4.2.2. Market Size and Forecast, by Region
4.2.3. Market Analysis, by Country
4.3. Bacillus
4.3.1. Key Market Trends and Opportunities
4.3.2. Market Size and Forecast, by Region
4.3.3. Market Analysis, by Country
4.4. Others
4.4.1. Key Market Trends and Opportunities
4.4.2. Market Size and Forecast, by Region
4.4.3. Market Analysis, by Country
Chapter 5: Direct Fed Microbial Market, by Livestock
5.1. Overview
5.1.1. Market Size and Forecast, by Livestock
5.2. Swine5.2.1. Market Size and Forecast, by Region
5.2.2. Market Analysis, by Country
5.3. Poultry
5.3.1. Market Size and Forecast, by Region
5.3.2. Market Analysis, by Country
5.4. Ruminants
5.4.1. Market Size and Forecast, by Region
5.4.2. Market Analysis, by Country
5.5. Aquatic Animals
5.5.1. Market Size and Forecast, by Region
5.5.2. Market Analysis, by Country
5.6. Others
5.6.1. Market Size and Forecast, by Region
5.6.2. Market Analysis, by Country
Chapter 6: Direct Fed Microbial Market, by Region
6.1. Overview
6.1.1. Market Size and Forecast
6.2. North America
6.2.1. Key Market Trends and Opportunities
6.2.2. Market Size and Forecast, by Type
6.2.3. Market Size and Forecast, by Livestock
6.2.4. Market Size and Forecast, by Country
6.2.4.1. U. S. Market Size and Forecast, by Type
6.2.4.2. U. S. Market Size and Forecast, by Livestock
6.2.4.3. Canada Market Size and Forecast, by Type
6.2.4.4. Canada Market Size and Forecast, by Livestock
6.2.4.5. Mexico Market Size and Forecast, by Type
6.2.4.6. Mexico Market Size and Forecast, by Livestock
6.3. Europe6.3.1. Key Market Trends and Opportunities
6.3.2. Europe Market Size and Forecast, by Type
6.3.3. Europe Market Size and Forecast, by Livestock
6.3.4. Europe Market Size and Forecast, by Country
6.3.4.1. France Market Size and Forecast, by Type
6.3.4.2. France Market Size and Forecast, by Livestock
6.3.4.3. UK Market Size and Forecast, by Type
6.3.4.4. UK Market Size and Forecast, by Livestock
6.3.4.5. Germany Market Size and Forecast, by Type
6.3.4.6. Germany Market Size and Forecast, by Livestock
6.3.4.7. Spain Market Size and Forecast, by Type
6.3.4.8. Spain Market Size and Forecast, by Livestock
6.3.4.9. Rest of Europe Market Size and Forecast, by Type
6.3.4.10. Rest of Europe Market Size and Forecast, by Livestock
6.4. Asia-Pacific
6.4.1. Key Market Trends and Opportunities
6.4.2. Asia-Pacific Market Size and Forecast, by Type
6.4.3. Asia-Pacific Market Size and Forecast, by Livestock
6.4.4. Asia-Pacific Market Size and Forecast, by Country
6.4.4.1. Japan Market Size and Forecast, by Type
6.4.4.2. Japan Market Size and Forecast, by Livestock
6.4.4.3. China Market Size and Forecast, by Type
6.4.4.4. China Market Size and Forecast, by Livestock
6.4.4.5. India Market Size and Forecast, by Type
6.4.4.6. India Market Size and Forecast, by Livestock
6.4.4.7. Australia Market Size and Forecast, by Type
6.4.4.8. Australia Market Size and Forecast, by Livestock
6.4.4.9. Rest of Asia-Pacific Market Size and Forecast, by Type
6.4.4.10. Rest of Asia-Pacific Market Size and Forecast, by Livestock
6.5. LAMEA
6.5.1. Key Market Trends and Opportunities
6.5.2. LAMEA Market Size and Forecast, by Type
6.5.3. LAMEA Market Size and Forecast, by Livestock
6.5.4. LAMEA Market Size and Forecast, by Country
6.5.4.1. Brazil Market Size and Forecast, by Type
6.5.4.2. Brazil Market Size and Forecast, by Livestock
6.5.4.3. Saudi Arabia Market Size and Forecast, by Type
6.5.4.4. Saudi Arabia Market Size and Forecast, by Livestock
6.5.4.5. Rest of LAMEA Market Size and Forecast, by Type
6.5.4.6. Rest of LAMEA Market Size and Forecast, by Livestock
6.5.4.7. Rest of LAMEA Market Size and Forecast, by End-user
Chapter 7: Company Profiles
7.1. Adisseo
7.1.1. Company Overview
7.1.2. Company Snapshot
7.1.3. Operating Business Segments
7.1.4. Product Portfolio
7.2. Archer-Daniels-Midland Company
7.2.1. Company Overview
7.2.2. Company Snapshot
7.2.3. Operating Business Segments
7.2.4. Product Portfolio
7.3. Basf Se (Basf Corporation)
7.3.1. Company Overview
7.3.2. Company Snapshot
7.3.3. Operating Business Segments
7.3.4. Product Portfolio
7.3.5. Business Performance
7.4. Bio-Vet
7.4.1. Company Overview
7.4.2. Company Snapshot
7.4.3. Operating Business Segments
7.4.4. Product Portfolio
7.5. Chr. Hansen A/S
7.5.1. Company Overview
7.5.2. Operating Business Segments
7.5.3. Product Portfolio
7.5.4. Business Performance
7.6. E. I. Du Pont De Nemours and Company
7.6.1. Company Overview
7.6.2. Company Snapshot
7.6.3. Operating Business Segments
7.6.4. Product Portfolio
7.6.5. Business Performance
7.7. Evonik Industries AG
7.7.1. Company Overview
7.7.2. Company Snapshot
7.7.3. Operating Business Segments
7.7.4. Product Portfolio
7.9. Kemin Industries, Inc.
7.9.1. Company Overview
7.9.2. Operating Business Segments
7.9.3. Product Portfolio
7.10. Koninklijke Dsm N. V.
7.10.1. Company Overview
7.10.2. Company Snapshot
7.10.3. Operating Business Segments
7.10.4. Product Portfolio
7.10.5. Business Performance
7.11. Novozymes A/S
7.11.1. Company Overview
7.11.2. Company Snapshot
7.11.3. Operating Business Segments
7.11.4. Product Portfolio
7.11.5. Business Performance
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Adisseo
  • Bio-Vet
  • CHR. Hansen A/S
  • Evonik Industries Ag
  • Kemin Industries Inc.
  • Koninklijke DSM N. V
According to the report titled, "Direct Fed Microbial Market by Product Type, and Livestock: Opportunity Analysis and Industry Forecast, 2019-2026,"the global direct fed microbialmarket size was valued at $980 million in 2018, and is expected to reach $1,772 million by 2026, registering a CAGR of 7.5% from 2019 to 2026.

Direct-fed microbial contains live bacterial strains that help in the growth and development of animals. These beneficial organisms are replacing the use of antibiotics. However, due to the risk of development of antimicrobial-resistant organisms, the use of antibiotics as growth promoters for animal production has been banned. The administration of direct-fed microbial help to enhance the meat and milk production in animals such as cattle and poultry. In addition, these products modulate the immune response of animals and inhibit the growth of pathogenic organisms in the gastrointestinal tract of animals.

Increase in demand for meat & milk consumption and rise in profitability at same cost are the major factors driving the market growth of direct fed microbial market. Furthermore, significant surge in human population and increase in demand for protein content in the diet propel the market growth for direct-fed microbial. In addition, probiotics aid nutrient absorption by breaking down the complex compounds, which, in turn, helps to reduce the cost of animal production and increases the profitability of the animal producers. However, enforcement of stringent regulations regarding the vigorous usage of these microorganisms in animal diet and increase in cost of production are the major factors hampering thedirect fed microbial market growth. Conversely, ban on the usage of antibiotics in animal diet in the developed nations such the U.S., Germany, and the UK and rise in animal health concerns are anticipated to offer remunerative opportunities for market expansion in the near future.

By product, the lactobacillus segment accounted for 62% of the total direct fed microbialmarket share in 2018, and is expected to exhibit a prominent growth rate in the near future, owing to its increased usage in the livestock diet. Lactobacillus is the most widely used probiotics in the livestock diet, as it is considered safe and more beneficial as compared to the other bacterial species.
By livestock, the poultry segment dominated the direct fed microbial market in 2018, and is anticipated to maintain its dominance during the forecast period. This is attributed to the fact that poultry is the most consumed animal meat across the globe. Furthermore, individuals prefer poultry other than other livestock animals.

By region, North America accounted for the major direct fed microbial market share in 2018 and is expected to continue this trend, owing to easy availability of direct fed microbial products. Moreover, surge in the demand for probiotics and rise in awareness towards maintenance of healthy lifestyle in the region are the major reason that contributes to the growth of this market. On the other side, Asia-Pacific is estimated to register the fastest growth during the forecast period attributed to the increase in awareness regarding the use of direct fed microbial.

Key Findings Of The Study

Lactic acid bacteriaoccupied more than half share of the global direct fed microbial market in 2018.
The poultry segment in livestock segment is anticipated to grow with the highest CAGR throughout the forecast period.
The swine segment in livestock accounted for one-third share of the market in 2018.
Asia-Pacific is anticipated to grow at the highest rate during the analysis period, followed by LAMEA.
Note: Product cover images may vary from those shown
  • Koninklijke DSM N. V
  • Bio-Vet
  • Archer-Daniels-Midland Company
  • CHR. Hansen A/S
  • E. I. Du Pont De Nemours And Company
  • Novozymes A/S
  • Kemin Industries Inc.
  • BASF SE (BASF Corporation)
  • Evonik Industries Ag
  • Adisseo
Note: Product cover images may vary from those shown

The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.

They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.

They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:

  • Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic news articles and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast

Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.

Loading
LOADING...